In Part 2 of this two-part series on statistics in the social sciences, Fancy Comma, LLC’s Kelly Tabbutt discusses the importance of reliability and validity when interpreting statistical data.
Author Archives: Fancy Comma, LLC
Coronavirus, Travel, and Entrepreneurship: How to Make the Most of Lockdown Wanderlust?
In this post, Nidhi Parekh of The Shared Microscope discusses entrepreneurship and travel in COVID-19, and how working from home can set you up for remote work at your favorite vacation destinations once the pandemic is over.
Can We Make “Good” Journalism “Great”?
In this article, Fancy Comma, LLC’s Sheeva Azma talks about the importance of journalism and ways to make good journalism “great.”
5 Ways to Boost Productivity as a Freelancer
In this post, Nidhi Parekh from The Shared Microscope discusses simple ways freelancers can boost their productivity to get the most out of their workday.
How to Navigate COVID-19 as a Freelancer
Learn how to adapt business strategy during uncertain times such as the COVID-19 pandemic
How I Learned to Love Neuroplasticity — And Why You Should, Too
In this post, Fancy Comma, LLC’s Sheeva Azma talks about what neuroplasticity is and how it helps humans be more adaptable.
Genuinely Simple Ways to Achieve Balance in a Pandemic
Dawn Beauchamp shares how she has been able to achieve balance amidst the chaos of parenting, work, and life during the COVID-19 pandemic.
In the COVID-19 Pandemic, Science Reporting Matters
In this post, Fancy Comma, LLC’s Sheeva Azma reflects on the state of biomedical science journalism in the COVID-19 pandemic.
The Simplified Guide to Understanding Statistics in the Social Sciences, Part I: Numbers and Graphs
In Part 1 of this two-part series, Fancy Comma, LLC’s Kelly Tabbutt discusses the simplest ways to understand numbers and graphs when interpreting statistics in the social sciences.
How the Novavax Vaccine for COVID-19, A Protein Subunit Vaccine, Works
In this post, Nidhi Parekh of The Shared Microscope talks about Novavax, a protein subunit vaccine being developed for COVID-19.